CFS Clinical Selected C3i to Provide Technology Support Globally for their Proprietary Systems
C3i announced that it has been selected by CFS Clinical to provide global 24x365 multilingual technology support services for their Site Activation and Investigator Payment Services.
C3i, a global provider of service desk support and business process outsourcing (BPO) services for the life sciences industry, announced that it has been selected by CFS Clinical to provide global 24x365 multilingual technology support services for their Site Activation and Investigator Payment Services.
CFS Clinical is the leading technology-enabled service provider focused on site startup and investigator payments for clinical trials. The company was recently acquired by DrugDev – an interactive network and data sharing platform for 80,000+ clinical trial doctors worldwide. DrugDev and CFS’ combined capabilities create a powerful offering in finding, engaging and paying investigators.
The partnership between C3i and CFS Clinical started back in March 2013 with a training engagement. This included a 30-minute eLearning module developed in English and translated into a Spanish version. The high level of CFS’ satisfaction with the delivered training services led to expanding the partnership between the two companies, and as of February 28th, C3i is providing global 24x365 multilingual technology support services for CFS’ Site Startup and Global Payment Services systems. The service desk is supporting active clinical trial sites in nearly 50 countries and 12 languages, staffed out of C3i’s Sofia Operations Center. Later in 2014, additional languages will be added to manage CFS’ continued scaling, supported out of C3i’s Dalian Operations Center
”C3i’s industry and custom technology support expertise, reputation and global multilingual abilities were all factors that influenced our decision to select C3i in this endeavor. We already had a positive experience with C3i’s capabilities and professionalism, which they demonstrated by the earlier training development engagement”, said Greg Seminack, President of CFS Clinical. C3i’s ability to support proprietary applications was also a key factor in their selection of C3i as a partner.
“I am excited to welcome one of the leading specialty providers in the life sciences industry as our client,” said Joel Morse, CEO of C3i Inc. “C3i is fully committed to delivering a service desk support infrastructure that will ensure CFS’ customers worldwide receive the best experience with the company’s proprietary systems“.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
